Image

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

Research on ERCP and RFA for advanced pancreatic tumors.

Recruiting
18-85 years
All
Phase N/A

Pancreatic cancer, particularly when it spreads (metastatic pancreatic ductal adenocarcinoma or mPDAC), is a severe condition. Current treatments, like chemotherapy, only extend life by a few months. Radiofrequency ablation (RFA) is a technique that uses heat to destroy cancer cells. It is being explored for its potential to help patients with this type of cancer. This study focuses on patients whose cancer has spread to the liver. It involves applying RFA to the bile duct, where the cancer often causes blockage. The goal is to see if this can improve survival. Participants will be split into two groups: one will receive a metal stent in their bile duct, and the other will receive RFA followed by a stent. RFA is expected to help by destroying tumor tissue and improving bile flow.

  • Study involves two groups: one with RFA treatment and one without.
  • Participants must have limited cancer spread to the liver.
  • Includes patients aged 18-85 under chemotherapy.
Study details
    Pancreatic Cancer Metastatic to Liver

NCT07191418

Roberto Valente

29 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.